Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2025 Poal.co

892

Video that MSM fact checkers 'Deboonked' C0v|d Swab contains nano bots that go inside your brain https://www.youtube.com/watch?v=q0Mu_aCxmuA

Nanofiber-Reinforced Micro-Actuators: https://www.youtube.com/watch?v=ClgkCOrlQLo

Dr. Langer talking about putting drug cells in/on fibers https://youtu.be/ZOgobBrGYVM?t=871

https://link.springer.com/article/10.1007/s42247-021-00178-6 Nanotechnology: an emerging approach to combat COVID-19 " The efficiency of the vaccine can be improved by modifying the size, shape, and charge of the nanoparticles. The vaccine administration could be through intramuscular/subcutaneous injection, oral/intranasal mucosa,"

Mucoadhesive Electrospun Fibre-Based Technologies for Oral Medicine 2020; Jake G. Edmans 1,2, Katharina H. Clitherow 1,2, Craig Murdoch 1,* , Paul V. Hatton 1, Sebastian G. Spain 2 and Helen E. Colley 1: "Mucoadhesive devices prepared using electrospinning offer the potential to address these challenges by allowing unidirectional site-specific drug delivery through intimate contact with the mucosa and with high surface areas to facilitate drug release."

https://www.news-medical.net/news/20201125/COVID-19-vaccine-candidate-tested-preclinically-at-UAB-poised-for-Phase-1-clinical-study.aspx Intranasal vaccination is an attractive strategy, as the nasal mucosa represents the first-line barrier to SARS-CoV-2 entry before viral spread to the lung.

http://aptimmune.com/mucosal/ mucosal vaccines [spray used on pigs] https://www.mdpi.com/2079-4991/9/9/1331/htm Mussel-Inspired Fabrication of SERS Swabs for Highly Sensitive and Conformal Rapid Detection of Thiram Bactericides

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0051794 Biodegradable Nanoparticle-Entrapped Vaccine Induces Cross-Protective Immune Response "Biodegradable nanoparticle-based vaccine development research is unexplored in large animals and humans. "

https://3dheals.com/3d-printing-pharmaceuticals-and-drug-delivery-devices A bioinspired 3D‐printed painless microneedle array is fabricated, and the suitability of this microneedle patch for drug delivery during long‐term wear is demonstrated.

https://link.springer.com/chapter/10.1007/978-981-15-9169-3_16 Biomedical Application of Cotton and Its Derivatives

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0051794 Biodegradable nanoparticle-based vaccine development research is unexplored in large animals and humans. "For the use in the internal application, the biomaterials have to pass many in vitro and in vivo tests due to the final application. "

Rand Corp https://www.rand.org/content/dam/rand/pubs/monograph_reports/2005/MR1307.pdf "Edible vaccines" ...they even say "Key Barriers: "social and ethical rejection"

Video that MSM fact checkers 'Deboonked' C0v|d Swab contains nano bots that go inside your brain https://www.youtube.com/watch?v=q0Mu_aCxmuA Nanofiber-Reinforced Micro-Actuators: https://www.youtube.com/watch?v=ClgkCOrlQLo Dr. Langer talking about putting drug cells in/on fibers https://youtu.be/ZOgobBrGYVM?t=871 https://link.springer.com/article/10.1007/s42247-021-00178-6 Nanotechnology: an emerging approach to combat COVID-19 " The efficiency of the vaccine can be improved by modifying the size, shape, and charge of the nanoparticles. The vaccine administration could be through intramuscular/subcutaneous injection, oral**/intranasal mucosa**," Mucoadhesive Electrospun Fibre-Based Technologies for Oral Medicine 2020; Jake G. Edmans 1,2, Katharina H. Clitherow 1,2, Craig Murdoch 1,* , Paul V. Hatton 1, Sebastian G. Spain 2 and Helen E. Colley 1: "Mucoadhesive devices prepared using electrospinning offer the potential to address these challenges by allowing unidirectional site-specific drug delivery through intimate contact with the mucosa and with high surface areas to facilitate drug release." https://www.news-medical.net/news/20201125/COVID-19-vaccine-candidate-tested-preclinically-at-UAB-poised-for-Phase-1-clinical-study.aspx Intranasal vaccination is an attractive strategy, as the nasal mucosa represents the first-line barrier to SARS-CoV-2 entry before viral spread to the lung. http://aptimmune.com/mucosal/ mucosal vaccines [spray used on pigs] https://www.mdpi.com/2079-4991/9/9/1331/htm Mussel-Inspired Fabrication of SERS Swabs for Highly Sensitive and Conformal Rapid Detection of Thiram Bactericides https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0051794 Biodegradable Nanoparticle-Entrapped Vaccine Induces Cross-Protective Immune Response "Biodegradable nanoparticle-based vaccine development research is unexplored in large animals and humans. " https://3dheals.com/3d-printing-pharmaceuticals-and-drug-delivery-devices A bioinspired 3D‐printed painless microneedle array is fabricated, and the suitability of this microneedle patch for drug delivery during long‐term wear is demonstrated. https://link.springer.com/chapter/10.1007/978-981-15-9169-3_16 Biomedical Application of Cotton and Its Derivatives https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0051794 Biodegradable nanoparticle-based vaccine development research is unexplored in large animals and humans. "For the use in the internal application, the biomaterials have to pass many in vitro and in vivo tests due to the final application. " Rand Corp https://www.rand.org/content/dam/rand/pubs/monograph_reports/2005/MR1307.pdf "Edible vaccines" ...they even say "Key Barriers: "social and ethical rejection"

(post is archived)

You are currently inside a comment thread.
Click here to see all the comments (2).
[–] • 1 pt (edited )

Lol not sure if they've gotten around informed consent yet. Hope not. Skirting that is part of their . Even according to the WHO, you'd with those questions (https://vaccine-safety-training.org/simplified-and-key-messages.html). In some states like which they should by , have to warn you of before the appointment starts or is even scheduled.

(Check out this part of the "Prior to treatment of the eligible patient with an investigational product, the treating physician shall obtain written informed consent, consistent with the requirements of RCW 7.70.060(1), and signed by the eligible patient or, if the patient lacks the capacity to consent, his or her legally authorized representative. (2) Information provided in order to obtain the informed consent must, to the extent possible, include the following: (d) The potentially best and worst outcomes of using the investigational product and a realistic description of the most likely outcome. This description must include the possibility that new, unanticipated, different, or worse symptoms may result and that death could be hastened by the proposed treatment. The description must be based on the physician's knowledge of the proposed treatment in conjunction with an awareness of the eligible patient's condition)"